Thermo Fisher Revenues Jump 7 Percent in Q2 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported a 7 percent increase in revenues year over year and a nearly 15 percent increase in profits for its second quarter.

For the three months ended July 3, the company posted receipts of $2.65 billion, up from $2.48 billion in Q2 2009. The firm fell just short of analysts' consensus estimate of $2.66 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.